title: Subthalamic nucleus stimulation in patients with Parkinson's disease does not increase serum ghrelin levels.
authors.forename: J B
authors.initials: JB
authors.lastname: Corcuff
authors.forename: E
authors.initials: E
authors.lastname: Krim
authors.forename: F
authors.initials: F
authors.lastname: Tison
authors.forename: A
authors.initials: A
authors.lastname: Foubert-Sanier
authors.forename: D
authors.initials: D
authors.lastname: Guehl
authors.forename: P
authors.initials: P
authors.lastname: Burbaud
authors.forename: E
authors.initials: E
authors.lastname: Cuny
authors.forename: L
authors.initials: L
authors.lastname: Baillet
authors.forename: H
authors.initials: H
authors.lastname: Gin
authors.forename: V
authors.initials: V
authors.lastname: Rigalleau
authors.forename: C
authors.initials: C
authors.lastname: Perlemoine
mesh_terms: D046690:Deep Brain Stimulation; D054439:Ghrelin; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D010300:Parkinson Disease / Q000628:therapy*; D036361:Peptide Hormones / Q000097:blood*; D020531:Subthalamic Nucleus / Q000503:physiopathology*
chemical_list: D054439:Ghrelin; D036361:Peptide Hormones; D007980:Levodopa